Key result
Higher lean-to-visceral fat ratio is linked to ~79% lower odds of dyslipidemia in men.
Why the study?
Is a higher lean body mass to visceral fat mass ratio associated with lower odds of cardiometabolic disorders in the general US population?
Cross-Sectional (n=10,867)
Is a higher lean body mass to visceral fat mass ratio associated with lower odds of cardiometabolic disorders in the general US population?
Answers are grounded in this paper and cite their sources.
A higher ratio of lean mass index to visceral fat mass index is strongly and inversely associated with the prevalence of dyslipidemia, hypertension, and diabetes.
The literature has documented conflicting and inconsistent associations between muscle-to-fat ratios and metabolic diseases. Additionally, different adipose tissues can have contrasting effects, with visceral adipose tissue being identified as particularly harmful. This study aimed to explore the relationship between the ratio of the lean mass index (LMI) to the visceral fat mass index (VFMI) and cardiometabolic disorders, including dyslipidemia, hypertension, and diabetes, as previous research on this topic is lacking. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted in the United States and included 10,867 individuals. Logistic regression was employed to explore the association between LMI/VFMI and cardiometabolic disorders. Generalized additive models were utilized to examine the nonlinear relationships between variables. Data analysis revealed a consistent inverse association between ln(LMI/VFMI) and dyslipidemia, hypertension, and diabetes. Each 2.7-fold increase in LMI/VFMI (one unit of ln[LMI/VFMI]) was associated with lower odds ratios (ORs) for these conditions. In men, the ORs were 0.21 (95% CI 0.17-0.25) for dyslipidemia, 0.37 (95% CI 0.30-0.45) for hypertension, and 0.16 (95% CI 0.10-0.23) for diabetes. Similarly, in women, the ORs were 0.22 (95% CI 0.19-0.26), 0.51 (95% CI 0.42-0.61), and 0.19 (95% CI 0.13-0.27). Quartile analysis showed that participants in the highest quartile (Q4) had significantly lower ORs compared to those in the lowest quartile (Q1). In men, Q4 ORs were 0.18 (95% CI 0.14-0.23) for dyslipidemia, 0.30 (95% CI 0.23-0.39) for hypertension, and 0.11 (95% CI 0.06-0.20) for diabetes. In women, Q4 ORs were 0.12 (95% CI 0.10-0.15), 0.39 (95% CI 0.29-0.52), and 0.12 (95% CI 0.06-0.25), respectively. Dyslipidemia and diabetes demonstrated nonlinear patterns, while a linear association was found for hypertension. Subgroup analyses across various characteristics confirmed these findings with no substantial directional changes. Maintaining an appropriate ratio of LMI to VFMI may be associated with favorable metabolic health.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2025) conducted a cross-sectional in cardiometabolic disorders (n=10,867). Lean mass index to visceral fat mass index (LMI/VFMI) ratio vs. Lower LMI/VFMI ratio was evaluated on dyslipidemia (OR 0.21, 95% CI 0.17-0.25). A 2.7-fold increase in the lean mass to visceral fat mass ratio was associated with lower odds of dyslipidemia in men, hypertension, and diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: